Cargando…
A retrospective analysis of commonly prescribed medications and the risk of developing breast cancer related lymphedema
OBJECTIVES: Breast cancer related lymphedema (BCRL) is a common complication of current breast cancer treatment modalities, significantly lowering quality of life for these patients and often leading to recurrent infections. Here, based on pre-clinical literature, we aim to retrospectively evaluate...
Autores principales: | Meijer, Eelco FJ, Bouta, Echoe M, Mendonca, Clive, Skolny, Melissa N, Salama, Laura W, Taghian, Alphonse G, Padera, Timothy P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455025/ https://www.ncbi.nlm.nih.gov/pubmed/32864167 http://dx.doi.org/10.15761/crt.1000293 |
Ejemplares similares
-
Abstract QS48: Quantifying Lymphatic Contraction Using ICG Lymphography: A Novel Approach to Lymphedema Assessment
por: Tran, Bao Ngoc, et al.
Publicado: (2018) -
Establishing and Sustaining a Prospective Screening Program for Breast Cancer-Related Lymphedema at the Massachusetts General Hospital: Lessons Learned
por: Brunelle, Cheryl, et al.
Publicado: (2015) -
Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort
por: Swaroop, Meyha N., et al.
Publicado: (2015) -
Utilization of longitudinal ultrasound to quantify joint soft-tissue changes in a mouse model of posttraumatic osteoarthritis
por: Xu, Hao, et al.
Publicado: (2017) -
Lymphatic imaging to assess rheumatoid flare: mechanistic insights and biomarker potential
por: Rahimi, Homaira, et al.
Publicado: (2016)